Rice statistician Erzsébet Merényi is part of a team of researchers awarded $1 million by the Cancer Prevention and Research Institute of Texas to develop AI tools that can identify lethal forms of prostate cancer earlier and improve treatment selection.
A recent symposium organized by the ENRICH office and the Rice Neuroengineering Initiative as part of the Meeting of the Minds NeuroNetworking Series explored ethics and policy in brain science today, including in the context of psychedelic-assisted therapy.
Wade Adams, former director of the Richard E. Smalley Institute for Nanoscale Science and Technology at Rice, passed away Feb. 12 at the age of 78. A self-described “technical optimist,” Adams was not only an experienced researcher and educator but also an enthusiastic advocate of nanotechnology, which he defined as “making small stuff do big things” and viewed as offering potential solutions to pressing challenges, particularly in energy but also in clean water and medicine.
The Rice Biotech Launch Pad is launching a Rice Venture Creation Fellowship, a program providing recent doctoral graduates passionate about innovation and startup development with training and resources.
Nobel laureate M. Stanley Whittingham shared insights from his pioneering work on lithium-ion batteries and addressed the future of energy storage during the Adams-Hauge Fund Smalley Lecture in Materials Science and Nanoengineering delivered at Rice.
A team of researchers at Rice has developed an innovative AI-enabled, low-cost device that will make flow cytometry ⎯ a technique used to analyze cells or particles in a fluid using a laser beam ⎯ affordable and accessible.
Rice neuroscientist Valentin Dragoi and Ariana Andrei from the Houston Methodist Research Institute developed a detailed, step-by-step guide for deploying optogenetics in nonhuman primates, providing critical guidance for researchers working to advance understanding of the brain’s complex networks and their relationship with behavior.
Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand with focused ultrasound can significantly reduce tumor size and burden in prostate cancer models, according to a new study published in Advanced Science by researchers at Rice and Vanderbilt.
As a partner institution of the Center for Clinical and Translational Sciences at UTHealth Houston, Rice has received approximately $1.69 million in grant funding to support pilot projects, student training and collaborative research in bioengineering, informatics, team science and related areas.
The Rice Department of Computer Science and Ken Kennedy Institute invite Houston industry and community partners to an evening discussion on LLMs, DeepSeek and the future of generative AI.
The Rice lab of bioengineer Gang Bao and collaborators at Baylor College of Medicine have developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic disorders in this vital organ as well as in other organs and tissues.